Clinical Trials Support for new Arthritis Treatment.

EHG is supporting a multi-site phase 3 clinical trial study using the comparator medicine Tofacitinib in the development of a new innovative treatment against arthritis!

Through our sourcing and direct-to-site services we were able to push through this study on budget and in-time to support the sponsor’s requirements and more importantly to ensure the product comes to market for the benefit of patients requiring different treatments for their arthritis.